You are here

Article Text

Article menu
Download PDFPDF
Letter
Interferon treatment of childhood conjunctival lymphoma
  1. R S Lucas1,
  2. R Mortimore2,
  3. T J Sullivan3,
  4. M Waldie4
  1. 1Department of Ophthalmology, Royal Brisbane Hospital, Herston, Queensland 4029, Australia
  2. 2Queensland Medical Laboratory Consulting Pathologists, 60 Ferry Road, West End, Queensland 4101, Australia
  3. 3Department of Ophthalmology, Royal Brisbane Hospital, Herston, Queensland 4029, Australia
  4. 4Department of Ophthalmology, Royal Brisbane Hospital, Herston, Queensland 4029, Australia
  1. Correspondence to: Associate Professor Timothy John Sullivan, Eyelid, Lacrimal and Orbital Clinic, Department of Ophthalmology, Royal Brisbane Hospital, Herston, Queensland 4029, Australia; tjs{at}gil.com.au

https://doi.org/10.1136/bjo.87.9.1191

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Mucosa associated lymphoid tissue (MALT) lymphoma is the most common ocular adnexal lymphoid proliferation. These neoplastic lesions have a more indolent course than non-MALT lymphomas, are usually found in the older age groups (50–70 years), are usually limited to localised (stage I) disease at presentation, and radiotherapy and chemotherapy have been the mainstay of treatment.1

    Case report

    A 15 year old male was referred by an ophthalmologist after an 8 month history of unusual painless follicles at both nasal fornices (Fig 1A). There were no visual symptoms and, based on a working diagnosis of an atypical vernal reaction, topical steroid treatment had resulted in mild size reduction of the lesions. Incisional biopsy was performed after the lesions remained static for 3–4 months.

    Figure 1

    (A) Conjunctival MALT lymphoma, nasal fornix of left eye. (B) …

    View Full Text